alexa
Reach Us +44 1704 335730
Explaining the Recent Fish Oil Trial and#8220;Failuresand#8221; | OMICS International | Abstract
ISSN: 2153-0637

Journal of Glycomics & Lipidomics
Open Access

Like us on:

OMICS International organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)

Editorial

Explaining the Recent Fish Oil Trial “Failures”

James J. DiNicolantonio1, Asfandyar K. Niazi2, James H. O’Keefe3 and Carl J. Lavie4

1Department of Medicine, Wegmans Pharmacy, Ithaca, New York, USA

2Department of Medicine, Shifa College of Medicine, Islamabad, Pakistan

3Department of Medicine, Mid American Heart Institute, University of Missouri-Kansas City, Kansas City, Missouri, USA

4Department of Medicine, John Ochsner Heart and Vascular Institute, Ochsner Clinical School- The University of Queensland School of Medicine, New Orleans, LA and Pennington Biomedical Research Center, Baton Rouge, Louisiana, USA

*Corresponding Author:
Carl J. Lavie
Department of Medicine
John Ochsner Heart and Vascular Institute
Ochsner Clinical School - The University of Queensland School of Medicine
1514 Jefferson Highway, New Orleans, LA 70121, USA
Tel: 504-842-5874
Fax: 504-842-5875
E-mail: [email protected]

Received date: November 09, 2012; Accepted date: November 12, 2012; Published date: November 15, 2012

Citation: DiNicolantonio JJ, Niazi AK, O’Keefe JH, Lavie CJ (2012) Explaining the Recent Fish Oil Trial “Failures”. J Glycomics Lipidomics 3:e112. doi: 10.4172/2153-0637.1000e112

Copyright: © 2012 DiNicolantonio JJ, et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

Abstract

Leave Your Message 24x7
Top